AUG 27·SEC EDGARLow
HANEY CECIL D sold $361K of THC
HANEY CECIL D sold 1,300 shares of TENET HEALTHCARE CORP (THC) at $278.03 ($0.36M total) on 2026-08-24.
StockNYSE · US · USDHealthcare · Medical Care Facilities
$THC
TENET HEALTHCARE CORP
Price · $THCvia TradingView
AI sentiment · 7d2 articles
- Bullish
- 1
- Neutral
- 1
- Bearish
- 0
Insider · 30dAll trades →
- Buys
- — 0 txs
- Sells
- $32.7M 10 txs
Sutaria Saumya5× · $27.6M
10b5-1 share of filings0%
Top stories · $THCMore →
AUG 27·SEC EDGAR
Sutaria Saumya sold $27.6M of THC
Sutaria Saumya (CEO) sold 100,000 shares of TENET HEALTHCARE CORP (THC) at an average of $276.36 ($273.34–$278.90, $27.64M total) across 5 trades over 2026-08-24 to 2026-08-25.
AUG 24·stocktitan.net
Tenet Healthcare (THC): Sutaria files 50,000-share resale notice
Tenet Healthcare (THC) received a notice for a proposed resale of 50,000 shares of its common stock, valued at $13.94 million, by Saumya S. Sutaria. The shares, acquired as compensation, are set to vest in early 2025 and may be sold on August 24, 2026. Tenet has 80.52 million shares outstanding.
THC sentiment & insider activity
Over the past 7 days, alphai's AI scored 2 news stories mentioning THC (TENET HEALTHCARE CORP). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.
Recent THC coverage spans earnings, insider activity and regulation.
In the last 30 days, THC insiders filed 10 SEC Form 4 transactions — no purchases and 10 sales ($32.7M). The most active reporter was Sutaria Saumya, CEO, with 5 filings.
What's driving THC
The insider sale may signal weak confidence from a director, potentially pressuring the stock lower.
Large insider sell may signal confidence concerns, likely pressure THC stock lower.
Potential modest increase in share supply could exert slight downward pressure on THC price.
Improved profitability and operating leverage indicate bullish outlook.
The article frames a bullish fundamental reset for Tenet via an earnings beat plus raised guidance, supporting momentum and valuation re-rating.
alphai scores every news story that mentions THC with an AI model for sentiment and relevance, and aggregates insider trades from TENET HEALTHCARE CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $THC
Score
HANEY CECIL D sold $361K of THC
HANEY CECIL D sold 1,300 shares of TENET HEALTHCARE CORP (THC) at $278.03 ($0.36M total) on 2026-08-24.
1 min readSutaria Saumya sold $27.6M of THC
Sutaria Saumya (CEO) sold 100,000 shares of TENET HEALTHCARE CORP (THC) at an average of $276.36 ($273.34–$278.90, $27.64M total) across 5 trades over 2026-08-24 to 2026-08-25.
1 min readTenet Healthcare (THC): Sutaria files 50,000-share resale notice
Tenet Healthcare (THC) received a notice for a proposed resale of 50,000 shares of its common stock, valued at $13.94 million, by Saumya S. Sutaria. The shares, acquired as compensation, are set to vest in early 2025 and may be sold on August 24, 2026. Tenet has 80.52 million shares outstanding.
1 min read
Medtronic vs. Tenet Healthcare: Which Healthcare Stock Offers Better Long-Term Growth?
Medtronic (MDT) and Tenet Healthcare (THC) present distinct growth prospects. MDT reported its highest annual revenue growth in a decade, driven by cardiac ablation solutions and investments in innovation. THC saw a 52.2% increase in adjusted EPS and 6.8% revenue growth, with margin expansion in hospitals. Investors must choose between MDT's innovation-led recovery and THC's operational improvements.
3 min readTenet Healthcare stock hits all-time high at 270.79 USD
Tenet Healthcare (THC) stock hit an all-time high of $270.79, up 54.4% over the past year. The company reported strong Q2 2026 earnings, exceeding expectations with $6.12 EPS on $5.63B revenue. Analysts raised price targets, with UBS setting the highest at $308. THC's P/E ratio is 10.46, and PEG ratio is 0.15, suggesting attractive valuation.
4 min read
Can Tenet Healthcare's Hospital Growth Keep Earnings Momentum Going?
Tenet Healthcare reported Q2 2026 Hospital Operations results, citing 2.6% YoY growth in adjusted admissions and 3.3% higher revenue per adjusted admission. Hospital adjusted EBITDA rose 22.3% to $762 million and margin expanded to 18% from 15.6%. Exchange revenues fell 17% and 2026 Hospital adjusted EBITDA guidance is $2.67-$2.81B.
4 min readTenet Healthcare Corporation (THC) Hits Fresh High: Is There Still Room to Run?
Tenet Healthcare (THC) shares rose 34.1% over the past month and reached a new 52-week high of $270.57. The article cites four straight quarters of positive earnings surprises, with last reported EPS $6.12 vs $4.08 consensus (July 23, 2026). Current-year estimates: EPS $19.85 on $22.17B revenue; Zacks Rank #1 Strong Buy.
4 min readIs Tenet Healthcare (THC) Overvalued Following Higher 2026 Adjusted EPS Guidance?
Simply Wall St reports Tenet Healthcare (THC) is in focus after a “golden cross” and higher 2026 adjusted EPS guidance. It cites strong recent stock performance, with 30-day return of 45.38% and YTD return of 33.89%. A valuation narrative sets fair value at $250 versus a $267.05 close, citing differing analyst earnings views.
4 min read
Tenet Healthcare’s (THC) Turnaround Is Working, but Can Its Growth Last?
Tenet Healthcare (NYSE:THC) reported fiscal Q2 2026 results that beat estimates and raised its full-year outlook. Adjusted EPS rose 52.2% to $6.12 and net operating revenue increased 6.8% to $5.63B. Hospital adjusted EBITDA margin expanded to 18.0%. Guidance: adjusted EBITDA $4.83B-$5.03B and net operating revenue $21.9B-$22.5B.
5 min readRomo Tammy sold $2.0M of THC
Romo Tammy sold 7,422 shares of TENET HEALTHCARE CORP (THC) at an average of $263.03 ($260.83–$264.15, $1.95M total) across 2 trades over 2026-08-06 to 2026-08-07.
1 min read